Bayer Schering Pharma AG Reports 2009 China Revenue Of €530 Million
This article was originally published in PharmAsia News
Executive Summary
Bayer Schering Pharma AG recently reported strong growth in its China operations in 2009, achieving an annual growth rate of 28 percent and total revenue of €530 million